ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9724
0.00%
Brent Oil
82.765
0.00%
Bitcoin
64,275.37
2.21%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Oncolytics Biotech Inc (ONCY)

  7. Oncolytics Biotech Inc (ONCY) Noticias

ONCY

Oncolytics Biotech (ONCY)

Oncolytics Biotech Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:ONCY
FechaHoraFuenteTítuloSímboloCompañía
07/03/202415:06Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
26/09/202307:00PR Newswire (US)THE PANCREATIC CANCER ACTION NETWORK SELECTS ONCOLYTICS BIOTECH® INC. TO RECEIVE $5 MILLION THERAPEUTIC ACCELERATOR AWARD TO DEVELOP LEADING-EDGE TREATMENTSNASDAQ:ONCYOncolytics Biotech Inc
22/06/202308:23Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ONCYOncolytics Biotech Inc
03/03/202310:24Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:ONCYOncolytics Biotech Inc
09/12/202211:25TipRanksOncolytics Biotech (ONCY) Receives a Buy from Maxim GroupNASDAQ:ONCYOncolytics Biotech Inc
02/12/202211:25TipRanksMaxim Group Sticks to Its Buy Rating for Oncolytics Biotech (ONCY)NASDAQ:ONCYOncolytics Biotech Inc
23/11/202205:30TipRanksWall Street Analysts Are Bullish on Top Healthcare PicksNASDAQ:ONCYOncolytics Biotech Inc
22/11/202211:15TipRanksMaxim Group Reaffirms Their Buy Rating on Oncolytics Biotech (ONCY)NASDAQ:ONCYOncolytics Biotech Inc
18/08/202205:15TipRanksH.C. Wainwright Remains a Buy on Oncolytics Biotech (ONCY)NASDAQ:ONCYOncolytics Biotech Inc
15/07/202205:15TipRanksH.C. Wainwright Thinks Oncolytics Biotech’s Stock is Going to RecoverNASDAQ:ONCYOncolytics Biotech Inc
16/06/202215:22Edgar (US Regulatory)Amended Registration Statement for Securities of Certain Canadian Issuers Under the Securities Act of 1933 (f-10/a)NASDAQ:ONCYOncolytics Biotech Inc
10/06/202216:14Edgar (US Regulatory)Appointment of Agent for Service of Process and Undertaking (f-x)NASDAQ:ONCYOncolytics Biotech Inc
10/06/202205:01Edgar (US Regulatory)Registration Statement for Securities of Certain Canadian Issuers Under the Securities Act of 1933 (f-10)NASDAQ:ONCYOncolytics Biotech Inc
11/04/202205:15TipRanksAnalysts Offer Insights on Healthcare Companies: Oncolytics Biotech (ONCY), Stealth Biotherapeutics (MITO) and Genocea Biosciences (GNCA)NASDAQ:ONCYOncolytics Biotech Inc
07/03/202205:25TipRanksAnalysts’ Top Healthcare Picks: Check-Cap (CHEK), Axsome Therapeutics (AXSM)NASDAQ:ONCYOncolytics Biotech Inc
05/03/202210:05TipRanksLeede Jones Gable Thinks Oncolytics Biotech’s Stock is Going to RecoverNASDAQ:ONCYOncolytics Biotech Inc
10/01/202210:57PR Newswire (US)New Developments in Fight Against Blood Cancers, in Leadup to US$17.1 Billion Market by 2024NASDAQ:ONCYOncolytics Biotech Inc
05/03/202116:08Edgar (US Regulatory)Voluntary Supplemental Material Filed Pursuant to Section 11(a) of the Securities Act of 1933 by Foreign Issuers (suppl)NASDAQ:ONCYOncolytics Biotech Inc
26/08/202009:15Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:ONCYOncolytics Biotech Inc
16/06/202005:00Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ONCYOncolytics Biotech Inc
12/12/201806:00GlobeNewswire Inc.Oncolytics Biotech® Announces First Patient Treated in Study Combining Pelareorep, Carfilzomib and the Checkpoint Inhibitor ...NASDAQ:ONCYOncolytics Biotech Inc
03/12/201806:00GlobeNewswire Inc.Oncolytics Biotech® Announces Increased PD-L1 Expression When Combining Pelareorep with a Proteasome Inhibitor in Poster Pr...NASDAQ:ONCYOncolytics Biotech Inc
29/11/201806:00GlobeNewswire Inc.Oncolytics Biotech® Announces Appointment of Rita Laeufle, M.D., as Chief Medical OfficerNASDAQ:ONCYOncolytics Biotech Inc
26/11/201807:00GlobeNewswire Inc.Oncolytics Biotech® Announces First Patient Treated in Phase 2 Study Combining Pelareorep and Keytruda® in Advanced Pancrea...NASDAQ:ONCYOncolytics Biotech Inc
13/11/201806:00GlobeNewswire Inc.Oncolytics Biotech® Announces Attendance of Upcoming ConferencesNASDAQ:ONCYOncolytics Biotech Inc
12/11/201806:00GlobeNewswire Inc.Oncolytics Biotech® Reports 2018 Third Quarter Financial Results and Provides Corporate UpdateNASDAQ:ONCYOncolytics Biotech Inc
09/11/201806:00GlobeNewswire Inc.Oncolytics Biotech® Announces Presentation at the Society for Immunotherapy of Cancer 2018 Annual Meeting Showcasing Upregul...NASDAQ:ONCYOncolytics Biotech Inc
05/11/201806:00GlobeNewswire Inc.Oncolytics Biotech® to Host Conference Call to Discuss Third Quarter Financial Results and Corporate HighlightsNASDAQ:ONCYOncolytics Biotech Inc
01/11/201806:00GlobeNewswire Inc.Oncolytics Biotech® Announces Abstract for ASH Annual Meeting & Exposition Demonstrating Pelareorep Increases PD-L1 Expressi...NASDAQ:ONCYOncolytics Biotech Inc
24/10/201819:25GlobeNewswire Inc.Oncolytics Biotech® Establishes New At-The-Market FacilityNASDAQ:ONCYOncolytics Biotech Inc
 Showing the most relevant articles for your search:NASDAQ:ONCY

Su Consulta Reciente

FX
EURUSD
Euro vs US Dollar
NYSE
AXP
American Express
SPI
SP500
S&P 500
NYSE
MRK
Merck
FX
USDMXN
US Dollar vs MXN
NASDAQ
AAPL
Apple
NYSE
KO
Coca Cola
NASDAQ
MSFT
Microsoft
PM
XAUUSD
Gold vs US Dollar
CCOM
OILBRENT
Brent Oil
AMEX
XLE
Energy Select Sector SPDR
NYSE
JPM
JP Morgan Chase
AMEX
XLF
Financial Select Sector
CCOM
US500
US 500
AMEX
XLV
Health Care Select Sector
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados